FULC – fulcrum therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Bullish Analyst Sentiment on Fulcrum Therapeutics (FULC) Following Positive Updates from Phase 1b PIONEER Study [Yahoo! Finance]
Fulcrum Therapeutics (NASDAQ:FULC) was given a new $18.00 price target on by analysts at Truist Financial Corporation.
Fulcrum Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Fulcrum Therapeutics (NASDAQ:FULC) had its price target raised by analysts at Bank of America Corporation from $6.00 to $7.00. They now have an "underperform" rating on the stock.
Fulcrum Therapeutics Announces Proposed $150.0 Million Public Offering of Common Stock
Form 4 Fulcrum Therapeutics, For: Dec 15 Filed by: Oltmans Curtis Gale
Form 144 Fulcrum Therapeutics, Filed by: Oltmans Curtis Gale
Form 8-K Fulcrum Therapeutics, For: Dec 10
Form 424B5 Fulcrum Therapeutics,
Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.